Global beauty company L’Oréal is reported to be in advanced discussions to acquire a majority stake in Innovist, the parent company of several fast-growing direct-to-consumer (D2C) brands in India, including Bare Anatomy, Chemist at Play, Sunscoop, and Vinci Botanicals. This potential transaction may become one of the most notable D2C acquisitions in 2025, reflecting ongoing momentum in India’s D2C market.
Reports indicate that the acquisition could value Innovist between $350 million and $450 million (approximately ₹3,240–₹4,170 crore), underscoring current trends of strong valuations for D2C startups and heightened investor confidence in the Indian D2C sector. If completed, this deal could stand out as a significant event within the beauty and personal care industry, potentially exceeding the scale of recent comparable transactions.
The move illustrates how global companies are increasingly engaging with emerging D2C startups and digitally native brands to expand their presence in high-growth markets like India. For L’Oréal, acquiring Innovist aligns with its strategic objective to grow its footprint in India’s D2C beauty and skincare sector, which is undergoing rapid evolution.
Innovist has developed a robust portfolio of science-driven, digitally focused brands that align well with contemporary consumer preferences. Its emphasis on efficacy, transparency, and targeted solutions has been instrumental in driving the growth of premium D2C brands in India.
This possible acquisition also reflects wider trends shaping the D2C market in 2025, where consolidation through acquisitions is becoming more prevalent. Large FMCG players and multinational corporations are increasingly investing in VC-backed D2C brands to accelerate innovation, shorten product launch cycles, and connect with digitally native customers. This pattern is evident across various categories, including beauty, wellness, nutrition, and personal care.
In the Indian context, strategic acquisitions have become more frequent. For example, Hindustan Unilever purchased the remaining 49% in Oziva for ₹824 crore, and Marico acquired a majority stake in plant-based nutrition brand Cosmix. USV’s acquisition of a significant share in Wellbeing Nutrition and ITC’s expansion with Yoga Bar further illustrate how private equity and corporate investments are reshaping the competitive landscape in India’s D2C space.
If the Innovist deal is finalized, it would reinforce the strength of leading funded D2C brands and highlight the increasing emphasis on D2C growth plans in India. It would also demonstrate how global investors are placing significant bets on the country’s digital-first consumer market.
From a strategic standpoint, Innovist’s focus on digital-first brand building, combined with strong research and development and omnichannel distribution capabilities, fits well with evolving trends that blend online and offline retail. The brand’s ability to operate seamlessly across channels exemplifies shifts occurring at the intersection of D2C retail and e-commerce.
This development further cements India’s status as a key hub for D2C innovation, attracting both domestic and international investment. As the ecosystem continues to expand, it draws attention to developments in product launches, supply chain innovations, and consumer-oriented offerings.
Included in the wider context of D2C developments in India, this potential acquisition highlights prevailing themes such as market consolidation, strong brand valuations, and growing global interest. With multiple funding rounds, acquisitions, and growth strategies underway, India is becoming a strategic market for both international and local players.
Should the transaction close, L’Oréal’s acquisition of Innovist could reshape competitive dynamics within India’s D2C beauty and skincare sectors, establishing new standards for scale, innovation, and global integration in the direct-to-consumer market.
